Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity, Journal of Antimicrobial Chemotherapy, June 2014, Oxford University Press (OUP),
DOI: 10.1093/jac/dku199.
You can read the full text:
Contributors
The following have contributed to this page
